Cannabis use in first episode psychosis: Meta-analysis of prevalence, and the time course of initiation and continued use. (Q38569243)

4 September 2017

0 references

Cannabis use in first episode psychosis: Meta-analysis of prevalence, and the time course of initiation and continued use. (English)

1 reference

4 September 2017

1 reference

1 reference

Hannah Myles

1

1 reference

PubMed ID

26286531

4 September 2017

Nicholas Myles

series ordinal

2

1 reference

PubMed ID

26286531

4 September 2017

Matthew Large

series ordinal

3

1 reference

4 September 2017

18 August 2015

1 reference

Australian and New Zealand Journal of Psychiatry

4 September 2017

1 reference

4 September 2017

50

1 reference

4 September 2017

3

1 reference

4 September 2017

208-219

1 reference

Impact of an early psychosis program on substance use.

4 September 2017

1 reference

https://api.crossref.org/works/10.1177%2F0004867415599846

Role of Environmental Confounding in the Association between FKBP5 and First-Episode Psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415599846

Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415599846

Cannabis use in children and adolescents with first episode psychosis: influence on psychopathology and short-term outcome (CAFEPS study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415599846

Cannabis use and involuntary admission may mediate long-term adherence in first-episode psychosis patients: a prospective longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415599846

Temporal relationship of first-episode non-affective psychosis with cannabis use: a clinical verification of an epidemiological hypothesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415599846

Screening for substance use disorders in first-episode psychosis: implications for readmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415599846

Peripheral endocannabinoid system dysregulation in first-episode psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415599846

Motivational intervention to reduce cannabis use in young people with psychosis: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415599846

Cannabis use and duration of untreated psychosis: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415599846

Pathways from cannabis to psychosis: a review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415599846

Prevalence of substance misuse in first-episode psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415599846

Citation bias in reported smoking prevalence in people with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415599846

Association between cannabis use, psychosis, and schizotypal personality disorder: findings from the National Epidemiologic Survey on Alcohol and Related Conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415599846

Cannabis use and psychiatric and cogitive disorders: the chicken or the egg?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415599846

Daily use, especially of high-potency cannabis, drives the earlier onset of psychosis in cannabis users

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415599846

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415599846

Continued cannabis use and outcome in first-episode psychosis: data from a randomized, open-label, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415599846

Medication adherence mediates the impact of sustained cannabis use on symptom levels in first-episode psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415599846

Cannabis use and the course of schizophrenia: 10-year follow-up after first hospitalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415599846

Cannabis and first-episode psychosis: different long-term outcomes depending on continued or discontinued use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415599846

Substance-abusing schizophrenics: do they self-medicate?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415599846

Cannabis use and the risk of developing a psychotic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415599846

Naturalistic follow-up of co-morbid substance use in schizophrenia: the West London first-episode study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415599846

Specialized psychosocial treatment plus treatment as usual (TAU) versus TAU for patients with cannabis use disorder and psychosis: the CapOpus randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415599846

Treatment of cannabis use disorders in people with schizophrenia spectrum disorders - a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415599846

Rate of cannabis use disorders in clinical samples of patients with schizophrenia: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415599846

One year follow-up of alcohol and illicit substance use in first-episode psychosis: does gender matter?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415599846

The impact of substance use disorders on clinical outcome in 643 patients with first-episode psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415599846

Measurement and reporting of the duration of untreated psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415599846

Cannabis Use and Earlier Onset of Psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415599846

Meta-analysis of self-reported substance use compared with laboratory substance assay in general adult mental health settings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415599846

The effect of cannabis use and cognitive reserve on age at onset and psychosis outcomes in first-episode schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415599846

Cannabis abuse is associated with decision-making impairment among first-episode patients with schizophrenia-spectrum psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415599846

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415599846

Does giving up substance use work for patients with psychosis? A systematic meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415599846

Tobacco use before, at, and after first-episode psychosis: a systematic meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415599846

Duration of untreated psychosis: a critical examination of the concept and its importance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415599846

Epidemiological factors associated with treated incidence of first-episode non-affective psychosis in Cantabria: insights from the Clinical Programme on Early Phases of Psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415599846

Does substance use disorder affect clinical expression in first-hospitalization patients with schizophrenia? Analysis of a prospective cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415599846

Genetic predisposition to schizophrenia associated with increased use of cannabis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415599846

Gone to Pot - A Review of the Association between Cannabis and Psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415599846

Reasons for cannabis use: patients with schizophrenia versus matched healthy controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415599846

Prevalence and impact of cannabis use disorders in adolescents with early onset first episode psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415599846

Cannabis use disorder and age at onset of psychosis--a study in first-episode patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415599846

Early course of schizophrenia in a representative Dutch incidence cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415599846

Correlates of substance misuse in patients with first-episode schizophrenia and schizoaffective disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415599846

Motivational interviewing and interaction skills training for parents to change cannabis use in young adults with recent-onset schizophrenia: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415599846

Cannabis use and first-episode psychosis: relationship with manic and psychotic symptoms, and with age at presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415599846

The impact of cannabis use on age of onset and clinical characteristics in first-episode psychotic patients. Data from the Psychosis Incident Cohort Outcome Study (PICOS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415599846

Impact of persistent substance misuse on 1-year outcome in first-episode psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415599846

Substance abuse in schizophrenia. A Singapore perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415599846

Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415599846

Cannabis users have higher premorbid IQ than other patients with first onset psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415599846

Cannabis use and outcome of recent onset psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0004867415599846

21 January 2018

Identifiers

DOI

10.1177/0004867415599846

1 reference

4 September 2017

1 reference

PubMed ID

26286531